PhilHealth To Cover 144 Hemodialysis Coverage Sessions Until December 31

PhilHealth said that its board of directors approved an increase in hemodialysis coverage sessions.

PHILHEALTH — The Philippine Health Insurance Corporation announced that it is increasing the limit for hemodialysis coverage sessions from 90 to 144 sessions, which can be availed until December 31, 2022.

PhilHealth

The state health insurer said in its advisory that its board of directors approved an increase in hemodialysis coverage sessions and this can be used by hemodialysis patients until the end of the year.

In addition, the state health insurer said that it will immediately issue the necessary guidelines through a Circular.

Meanwhile, the state health insurer said that it is directing all its regional offices and concerned healthcare facilities to “continue honoring all availments beyond the 90-session limit” as prescribed by an accredited physician.

PhilHealth Advisory 2022-0023

Senator Risa Hontiveros said last month that she will re-file a bill seeking to provide free 144 hemodialysis coverage sessions for Filipino senior citizens in the 19th Congress.

According to her, most senior citizens are dependent on meager pensions with no other source of income. She also noted that senior citizens are the “most vulnerable” among those with Chronic Kidney Disease.

READ ALSO: PhilHealth Says Contribution Increase Starting June Is Retroactively Effective In January

The senator also explained that a patient undergoing dialysis needs a total of 156 sessions for a complete year of treatment, which costs around PHP 12,000 weekly without subsidy.

Sa tingin ko ay dapat nang gawing batas ito para mabigyan ng kapanatagan ang mga lolo at lola nating umaasa rito. This isn’t just any privilege. It’s literally their lifeline. Dapat automatic na yung pagiging libre ng kanilang dialysis sessions,” the senator said at that time.

Thank you for visiting Newspapers.ph. You may express your reactions or thoughts in the comments section. Also, you may follow us on Facebook as well.

Leave a Comment